The Bank of Nova Scotia has filed a preliminary pricing supplement for its new financial product, the Autocallable Buffered Review Notes. This offering is linked to the performance of select State Street ETFs, marking a significant step in the bank's strategy to diversify its financial products. The move is noteworthy as it reflects the bank's commitment to innovation in the structured finance space.

This filing, dated November 12, 2026, is part of the bank's ongoing efforts to enhance its product offerings in a competitive market. The Autocallable Buffered Review Notes are designed to provide investors with potential returns while managing risk, particularly in volatile market conditions.

Background

The Bank of Nova Scotia, also known as Scotiabank, is a leading financial institution based in Toronto, Canada. It operates primarily in the state commercial banking sector (SIC 6022) and is listed on the New York Stock Exchange under the ticker symbol BNS. The bank offers a wide range of financial services, including personal and commercial banking, wealth management, and investment banking.

Recent filings by the bank include multiple 424B2 submissions, indicating a robust pipeline of financial products aimed at meeting diverse investor needs. The latest filing is part of a series of filings made on November 13, 2026, demonstrating the bank's active engagement in the capital markets.

What the Filing Says

The preliminary pricing supplement states, "The information in this Preliminary Pricing Supplement is not complete and may be changed. We may not sell these Notes until the Pricing Supplement is delivered in final form." This highlights the ongoing nature of the product's development and the bank's commitment to transparency in its offerings.

Additionally, the Notes are described as unsubordinated and unsecured debt securities, with payments subject to the credit risk of the bank. The filing also outlines the investment structure, including potential returns based on the performance of specific ETFs.

Impact

This development may affect a variety of stakeholders, including investors seeking innovative financial products, financial advisors looking to expand their investment options, and competitors in the banking and financial services sector. The introduction of these Notes could attract interest from both retail and institutional investors, further solidifying Scotiabank's position in the market.

What's Next

The filing does not specify what happens next, but it indicates that the Trade Date for the Notes is expected to be November 13, 2026, with settlement anticipated on November 18, 2026. Investors will be closely watching for the final pricing supplement, which will provide more detailed information about the product.

For more details, the filing can be accessed via the SEC's EDGAR database under accession number 0001839882-26-056090.